FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound represented in formula (I) or a pharmaceutically acceptable salt, diastereomer, racemate or mixture of diastereomers thereof, wherein ring A is pyridin-2-yl; (R0)n means that the hydrogen atoms in ring A are replaced by n R0 groups, where n is 0; Y1 is N; Y2 is a bond; Y1 is directly connected to N; Y3 is CR3; Y4 is CR4; R3 and R4 are independently hydrogen or halogen; W is CH2; Ra, Rb, Rc and Rd are defined as follows: (i) each of Ra and Rb independently represents hydrogen or C1-8alkyl; or Ra and Rb together with their associated carbon atom form a three to six membered saturated monocyclic ring; Rc is hydrogen, halogen, C1-8alkyl, C1-8alkoxy, or halogenated C1-8alkyl; or Rd is hydrogen or C1-8alkyl; or (ii) each of Ra and Rb independently represents hydrogen; or Rc is linked to Rd to form a three to six membered saturated monocyclic ring or a four to six membered saturated monoheterocyclic ring, wherein the heteroatom in the four to six membered saturated monoheterocyclic ring is O or N; and m is either 0 or 1. The invention also relates to intermediate compounds of formula (I-2b).
EFFECT: new compounds have been obtained that can be used in medicine as therapeutic agents for the treatment and prevention of pain and diseases associated with pain.
14 cl, 2 tbl, 23 ex
Title |
Year |
Author |
Number |
OPTICALLY PURE OXASPIRO-SUBSTITUTED PYRROLOPYRAZOLE DERIVATIVE, A METHOD OF ITS PRODUCTION AND ITS PHARMACEUTICAL USE |
2021 |
- Hu, Bin
- Zhang, Kai
- Guan, Huiping
|
RU2800295C1 |
SUBSTITUTED PYRAZOLE[1,5-a]PYRIMIDINE-7-AMINE DERIVATIVE, COMPOSITION AND PHARMACEUTICAL USE THEREOF |
2022 |
- Zhao, Zhiming
- Wu, Shenghua
- Hua, Mojia
- Hao, Shenglei
- Wang, Lulu
- Liu, Yang
|
RU2824118C1 |
2-(2-OXOINDOLIN-3-YLIDENE)METHYL-5-(2-HYDROXY-3-MORPHOLIN-4-YLPROPYL)-6,7-DIHYDRO-1-H-PYRROLE[3,2-C]PYRIDIN-4(5H)-ONE COMPOUNDS AND USE THEREOF AS PROTEIN KINASE INHIBITORS |
2008 |
- Tan Pehn Chzho
- Jan Tszjaljan
- Su Idun
- Chzhao Futsjan
|
RU2472792C2 |
TRICYCLIC COMPOUNDS AS EGFR INHIBITORS |
2021 |
- Chzhen, Shansun
- Den, Vej
- Kampos, Sebasten Andre
- Yan, Inin
- Tyan, Chzhenkhua
- Chzhen, Tsinmej
- Vu, Goshen
- Chzhao, Chzhivej
- Li, Lejlej
- Fu, Tszyamin
- Chzhao, Shuyun
|
RU2815022C1 |
AZABICYCLOOCTANE DERIVATIVES, METHOD FOR PREPARING AND USING AS DIPEPTIDYL PEPTIDASE IV INHIBITORS |
2007 |
- Tan Pehncho
- Lin' Chzhigan
- Ljuj Khehtszjun'
- Chzhao Futsjan
- Li Li
|
RU2447063C2 |
DERIVATIVES OF 6-AMINO QUINAZOLINE OR 3-CYANOQUINOLINE, METHODS OF THEIR PRODUCTION AND THEIR APPLICATION AS INHIBITORS OF RECEPTOR TYROZINE KINASES EGFR OR HER-2 |
2010 |
- Tan Pehn Cho
- Li Sin'
- Van Bin'
- Van Tszjun'
- Chehn' Litszjun'
|
RU2536102C2 |
OXOTHIOIMIDAZOLINE DERIVATIVES, METHODS FOR THEIR PRODUCTION AND APPLICATION IN MEDICINE AS ANDROGEN RECEPTOR INHIBITORS |
2013 |
- Lu Khetszyun
- Sun Pyaoyan
- Fej Khunbo
- Tszyan Khuntszyan
- Van Khaovej
- Dun Tsin
|
RU2639145C2 |
PYRIMIDINE COMPOUND WITH CONDENSED RINGS, ITS INTERMEDIATE COMPOUND, METHOD OF PRODUCING, COMPOSITION AND USE |
2016 |
- Syuj Tszushen
- Chzhan Nun
- Van Tinkhan
- Sun Tsinzhuj
- Van Yujguan
|
RU2732576C2 |
LIGAND CONJUGATE WITH CYTOTOXIC DRUG PREPARATION, METHOD AND APPLICATION THEREOF |
2016 |
- Syuj Tszyanyan
- Chzhan In
- Tsyuj Bolej
- Chzhan Fuyao
- Yuj Syuchzhao
- Lian Tszindun
- Tszyan Gujyan
- Chzhan Lyanshan
- Li An
- Van Yali
|
RU2708461C2 |
PYRAZOLOPYRIMIDONE OR PYRROLOTRIAZONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATIONS THEREOF |
2014 |
- Lyuj Khetszyun
- Sun Pyaoyan
- Guj Bin
- Dun Tsin
|
RU2674977C2 |